Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Giangaspero

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
The American Journal of Surgical Pathology|February 1, 1997
Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 casesF Giangaspero, G Cenacchi, L Losi, et al.
Chemical Research in Toxicology|July 1, 1988
Aliphatic diketones: influence of dicarbonyl spacing on amine reactivity and toxicityK Boekelheide, D C Anthony, F Giangaspero, et al.
Clinical Neuropathology|May 1, 1985
Regulatory peptides in neuronal neoplasms of the central nervous systemF Giangaspero, P C Burger, D A Budwit, et al.
Clinical Neuropathology|May 1, 1985
Familial amyloid polyneuropathy: report of a familyF Giangaspero, F Salvi, C Ceccarelli, et al.
Basic and Applied Histochemistry|January 1, 1984
Morpho-functional changes in normal cyclic endometriumG Pelusi, A Bondi, M P Morichelli, et al.
Acta Neuropathologica|January 1, 1987
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67F Giangaspero, C Doglioni, M T Rivano, et al.
Tumori|April 30, 1991
N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplificationM Badiali, A Pession, G Basso, et al.
Neuropathology and Applied Neurobiology|November 16, 2010
TP53, β-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettesM Gessi, A Zur Muehlen, L Lauriola, et al.
Pathologica|September 28, 2002
[The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases]L Riccioni, P Farabegoli, O Nanni, et al.
Pathologica|March 10, 2001
[Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria]M Bisceglia, V D'Angelo, S Parisi, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|February 1, 1997
Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 casesF Giangaspero, G Cenacchi, L Losi, et al.
Chemical Research in Toxicology|July 1, 1988
Aliphatic diketones: influence of dicarbonyl spacing on amine reactivity and toxicityK Boekelheide, D C Anthony, F Giangaspero, et al.
Clinical Neuropathology|May 1, 1985
Regulatory peptides in neuronal neoplasms of the central nervous systemF Giangaspero, P C Burger, D A Budwit, et al.
Clinical Neuropathology|May 1, 1985
Familial amyloid polyneuropathy: report of a familyF Giangaspero, F Salvi, C Ceccarelli, et al.
Basic and Applied Histochemistry|January 1, 1984
Morpho-functional changes in normal cyclic endometriumG Pelusi, A Bondi, M P Morichelli, et al.
Acta Neuropathologica|January 1, 1987
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67F Giangaspero, C Doglioni, M T Rivano, et al.
Tumori|April 30, 1991
N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplificationM Badiali, A Pession, G Basso, et al.
Neuropathology and Applied Neurobiology|November 16, 2010
TP53, β-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettesM Gessi, A Zur Muehlen, L Lauriola, et al.
Pathologica|September 28, 2002
[The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases]L Riccioni, P Farabegoli, O Nanni, et al.
Pathologica|March 10, 2001
[Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria]M Bisceglia, V D'Angelo, S Parisi, et al.
Pageof 12